CN101200740A - A method for preparing vitamin A fatty acid ester catalyzed by lipase - Google Patents
A method for preparing vitamin A fatty acid ester catalyzed by lipase Download PDFInfo
- Publication number
- CN101200740A CN101200740A CNA2007101798080A CN200710179808A CN101200740A CN 101200740 A CN101200740 A CN 101200740A CN A2007101798080 A CNA2007101798080 A CN A2007101798080A CN 200710179808 A CN200710179808 A CN 200710179808A CN 101200740 A CN101200740 A CN 101200740A
- Authority
- CN
- China
- Prior art keywords
- lipase
- vitamin
- fatty acid
- acid
- silica gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种生产维生素A脂肪酸酯的方法。更具体地说,本发明提供一种用脂肪酶催化维生素A与脂肪酸反应合成维生素A脂肪酸酯的方法,特别是在非水相体系中用固定化微生物脂肪酶催化反应合成维生素A脂肪酸酯的方法。The invention relates to a method for producing vitamin A fatty acid ester. More specifically, the present invention provides a method for synthesizing vitamin A fatty acid esters by using lipase to catalyze the reaction of vitamin A and fatty acid, especially in the non-aqueous phase system, using immobilized microbial lipase to catalyze the reaction to synthesize vitamin A fatty acid esters Methods.
背景技术Background technique
维生素A是人体必需的营养素之一,是儿童生长发育过程中必不可缺少的微量营养素,它参与机体多种生理过程,能维持和促进人体生长、发育、生殖和细胞膜的稳定性,对视觉的形成有明显的作用。由于其能抗炎、抗氧化、调节免疫、抗皮肤衰老、抗癌等功效已经被广泛应用于食品、药物、营养保健品、化妆品、饲料添加剂中。但是,维生素A是非常不稳定的,很容易在空气、光、高温下被氧化。而且维生素A对皮肤有刺激性。为了降低它的不稳定性和刺激性,可以将维生素A转化成维生素A酯。但长期以来,工业维生素A脂肪酸酯均是通过化学法来生产,用催化剂如甲醇钠、Grignard试剂等在高温高压下进行一系列催化反应来完成。不仅总转化率不高,而且还存在许多难以克服的缺点。如:催化剂有毒性、高温高压反应能耗高、副反应多,产物色泽深、分离和精制困难等,而且酸对设备腐蚀严重,不利于生产。随着生物技术的发展,特别是酶工程的研究,为生物催化剂合成脂肪酸酯提供了新的方法。与传统的化学法相比,酶法合成具有反应条件温和,特异性强,副反应少,对环境友好,产物品质高等特点。特别是在非水相中脂肪酶促反应,拓宽了酶的应用范围和领域,成为近年来酶学研究的热点。Vitamin A is one of the essential nutrients for the human body. It is an indispensable micronutrient in the growth and development of children. It participates in various physiological processes of the body and can maintain and promote the growth, development, reproduction and stability of the cell membrane of the human body. The formation has obvious effect. Because of its anti-inflammatory, anti-oxidation, immune regulation, anti-skin aging, anti-cancer and other effects, it has been widely used in food, medicine, nutritional health products, cosmetics, and feed additives. However, vitamin A is very unstable and is easily oxidized in air, light, and high temperature. And vitamin A is irritating to the skin. To reduce its instability and irritation, vitamin A can be converted to vitamin A esters. But for a long time, industrial vitamin A fatty acid esters have been produced by chemical methods, using catalysts such as sodium methoxide, Grignard reagent, etc. to carry out a series of catalytic reactions under high temperature and high pressure to complete. Not only the total conversion rate is not high, but also there are many shortcomings that are difficult to overcome. Such as: catalyst toxicity, high temperature and high pressure reaction, high energy consumption, many side reactions, deep color of product, difficulty in separation and purification, etc., and the acid corrodes the equipment seriously, which is not conducive to production. With the development of biotechnology, especially the research of enzyme engineering, a new method has been provided for biocatalyst synthesis of fatty acid esters. Compared with traditional chemical methods, enzymatic synthesis has the characteristics of mild reaction conditions, strong specificity, less side reactions, environmental friendliness, and high-quality products. Especially in the non-aqueous phase, the lipase-catalyzed reaction has broadened the application range and field of the enzyme, and has become a hot spot in enzymatic research in recent years.
“Inada,Yuji”在“维生素A酯的制备”(JP 62248495,1986)中公开了用O-甲氧基聚乙二醇修饰的荧光假单胞菌类脂肪酶来催化维生素A酯合成的方法。该方法的特点是用O-甲氧基聚乙二醇修饰后的脂肪酶作为催化剂,在水饱和的苯溶剂中,反应温度为25-30℃,利用维生素A醋酸酯和C5-C20脂肪酸包括戊酸、辛酸、癸酸、月桂酸、肉豆蔻酸、棕榈酸、油酸等,摩尔比为1∶10的条件下合成维生素A酯,维生素A酯收率达80-85%。该方法催化剂的制备复杂,成本高;而且使用有机溶剂苯作反应介质,苯有毒性,对环境有污染。而且,使用脂肪酸过多会增加后续分离提纯的困难性,必然导致产品成本高。"Inada, Yuji" in "Preparation of Vitamin A Esters" (JP 62248495, 1986) discloses a method for catalyzing the synthesis of vitamin A esters with O-methoxypolyethylene glycol-modified Pseudomonas fluorescens lipase . The method is characterized in that lipase modified by O-methoxy polyethylene glycol is used as a catalyst, and in a water-saturated benzene solvent, the reaction temperature is 25-30 ° C, and vitamin A acetate and C5-C20 fatty acids are used. Valeric acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, oleic acid, etc., synthesize vitamin A ester under the condition of molar ratio of 1:10, and the yield of vitamin A ester reaches 80-85%. The preparation of the catalyst in the method is complicated and the cost is high; moreover, the organic solvent benzene is used as the reaction medium, and the benzene is toxic and pollutes the environment. Moreover, using too much fatty acid will increase the difficulty of subsequent separation and purification, which will inevitably lead to high product costs.
“谭天伟,刘涛,尹春华”在“一种用固定化脂肪酶催化合成维生素A脂肪酸酯的方法”(中国专利申请200310116834.0,2003)中公开了一种用固定化脂肪酶催化合成维生素A脂肪酸酯的方法,是将底物维生素A醋酸酯和C10-C18脂肪酸或脂肪酸酯,按摩尔比在1∶1-1∶7的范围,与有机溶剂和固定化脂肪酶混合,固定化脂肪酶的用量是维生素A醋酸酯质量的0.2-5倍,在20-50℃的条件下,反应9-50小时,取出固定化脂肪酶,反应液经过分离、结晶得到维生素A脂肪酸酯;有机溶剂是含水量为0-1%的C6-C10饱和烷烃;固定化脂肪酶以硅藻土、树脂或织物膜为载体,载体上有酵母类脂肪酶,维生素A酯收率达80%左右。该方法虽然催化剂成本低,简化了分离提纯步骤,但维生素A酯收率不高,固定化酶的使用寿命低,给工业化生产增加了困难。"Tan Tianwei, Liu Tao, Yin Chunhua" disclosed a method for catalyzing the synthesis of vitamin A fatty acid esters with immobilized lipase (Chinese patent application 200310116834.0, 2003). The ester method is that the substrate vitamin A acetate and C10-C18 fatty acid or fatty acid ester are mixed with an organic solvent and an immobilized lipase in a molar ratio of 1:1-1:7 to immobilize the lipase The dosage is 0.2-5 times the quality of vitamin A acetate, react for 9-50 hours under the condition of 20-50°C, take out the immobilized lipase, and the reaction solution is separated and crystallized to obtain vitamin A fatty acid ester; organic solvent It is a C6-C10 saturated alkane with a water content of 0-1%. The immobilized lipase uses diatomaceous earth, resin or fabric film as a carrier, and there is yeast lipase on the carrier. The yield of vitamin A ester is about 80%. Although the method has low catalyst cost and simplifies the separation and purification steps, the yield of the vitamin A ester is not high, and the service life of the immobilized enzyme is low, which adds difficulties to industrial production.
目前的生物催化维生素A脂肪酸酯生产方法存在很多缺点,比如成本过高,维生素A脂肪酸酯产率低等。因此,需要提供一种简便的低成本、高产率制备维生素A脂肪酸酯的方法。The current biocatalytic method for producing vitamin A fatty acid ester has many disadvantages, such as high cost and low yield of vitamin A fatty acid ester. Therefore, it is necessary to provide a method for preparing vitamin A fatty acid esters with low cost and high yield.
发明内容Contents of the invention
本发明的一个目的是提供一种新的制备维生素A脂肪酸酯的方法。An object of the present invention is to provide a new method for preparing vitamin A fatty acid ester.
本发明使用脂肪酶尤其是固定化脂肪酶作为催化剂,催化维生素A与脂肪酸反应,合成维生素A脂肪酸酯。通过这种方法,实现了本发明的目的。优选地,所述方法在非水相体系中进行。The invention uses lipase, especially immobilized lipase, as a catalyst to catalyze the reaction of vitamin A and fatty acid to synthesize vitamin A fatty acid ester. By this method, the object of the present invention is achieved. Preferably, the method is carried out in a non-aqueous system.
与现有技术中的方法相比,在本发明所公开的方法中,脂肪酶用量少,反应时间短,维生素A转化率高,脂肪酸用量少,脂肪酶使用寿命长等优点,从而降低了生产成本,有利于工业化生产。Compared with the method in the prior art, in the method disclosed in the present invention, lipase consumption is few, and reaction time is short, and vitamin A conversion rate is high, fatty acid consumption is few, advantages such as lipase service life are long, thereby reduces The production cost is reduced, which is conducive to industrialized production.
具体实施方式Detailed ways
在本发明中,当描述维生素A脂肪酸酯的反应时,“维生素A”是指视黄醇(retinol);而在一般性的描述中,维生素A泛指能够在体内或体外直接或间接提供视黄醇来源的任何物质,包括但不限于视黄醇、视黄醛、视黄酸、及其各种衍生物,比如视黄醇醋酸酯、视黄醇脂肪酸酯、视黄醇棕榈酸酯等。In the present invention, when describing the reaction of vitamin A fatty acid ester, "vitamin A" refers to retinol (retinol); and in the general description, vitamin A generally refers to the ability to directly or indirectly provide Any substance that is a source of retinol, including but not limited to retinol, retinal, retinoic acid, and various derivatives thereof, such as retinyl acetate, retinyl fatty acid esters, retinyl palmitate Esters etc.
在一个方面,本发明提供用脂肪酶催化维生素A与脂肪酸反应来制备维生素A脂肪酸酯的方法。In one aspect, the present invention provides a method for preparing vitamin A fatty acid ester by using lipase to catalyze the reaction of vitamin A and fatty acid.
在本发明中,脂肪酶是指能够催化脂肪酸酯化反应及其逆反应脂肪酸酯水解的酶。很多生物体中都存在脂肪酶。本发明的脂肪酶可以来源于任何天然表达脂肪酶的生物。同样地,所述脂肪酶也可以是重组生产的,并且所述重组脂肪酶可以是突变体形式或非突变体形式。在一个实施方案中,所述脂肪酶可以被修饰,比如用聚乙二醇修饰。因此,在本发明中,凡提到“脂肪酶”或者特定来源的脂肪酶,均包括该脂肪酶的天然形式、重组形式、突变形式、变体形式及各种修饰形式。本发明的脂肪酶可以商业获得或者根据已知方法制备,脂肪酶的制备方法是本领域技术人员公知的,包括例如从天然来源中分离、化学合成、基因重组制备、随机诱变、定点诱变、及重组表达,以及各种蛋白质的修饰技术。这方面有众多的现有技术文件可供参考,包括例如Maniatis和Sambrook等,《分子克隆实验指南》,第2版,1989。In the present invention, lipase refers to an enzyme capable of catalyzing fatty acid esterification and its reverse reaction, hydrolysis of fatty acid ester. Lipase is present in many organisms. The lipase of the present invention may be derived from any organism that naturally expresses a lipase. Likewise, the lipase may also be produced recombinantly, and the recombinant lipase may be in mutant or non-mutant form. In one embodiment, the lipase may be modified, such as with polyethylene glycol. Therefore, in the present invention, any reference to "lipase" or lipase from a specific source includes the natural form, recombinant form, mutant form, variant form and various modified forms of the lipase. The lipase of the present invention can be obtained commercially or prepared according to known methods. The preparation methods of lipase are well known to those skilled in the art, including, for example, isolation from natural sources, chemical synthesis, gene recombination preparation, random mutagenesis, site-directed mutagenesis , and recombinant expression, as well as various protein modification techniques. Numerous prior art documents are available in this regard, including, for example, Maniatis and Sambrook et al., A Laboratory Guide to Molecular Cloning, 2nd Edition, 1989.
在一个实施方案中,所述脂肪酶来源于微生物,包括但不限于细菌和酵母。在一个实施方案中,所述脂肪酶来源于细菌,如假单胞菌属(Pseudomonas),优选荧光假单胞菌(Pseudomonas fluorescence)。在一个实施方案中,所述脂肪酶来源于酵母,尤其来源于酵母属(Saccharomyces)、假丝酵母属(Candida)和/或亚罗酵母属(Yarrowia),优选来源于选自以下的酵母:解脂假丝酵母(Candida lipolytica)、南极假丝酵母(Candida antarctica)、亚罗解脂酵母(Yarrowia lipolytica),特别是来源于解脂假丝酵母。此处所述“来源”表示表达脂肪酶基因的原始起源。例如,对于从A生物脂肪酶基因在B生物中表达而获得的脂肪酶,本发明中认为是来源于A生物。例如,本发明的脂肪酶可以来源于解脂假丝酵母、南极假丝酵母、亚罗解脂酵母、荧光假单胞菌等中的一种或多种。在一个实施方案中,本发明的脂肪酶来源于解脂假丝酵母。这些以及很多其它生物中的脂肪酶是本领域已知的,它们的制备方法可以在很多文献中发现,并且是在本领域技术人员的能力范围内。In one embodiment, the lipase is derived from microorganisms, including but not limited to bacteria and yeast. In one embodiment, the lipase is derived from bacteria, such as Pseudomonas, preferably Pseudomonas fluorescence. In one embodiment, the lipase is derived from yeast, especially from the genera Saccharomyces, Candida and/or Yarrowia, preferably from a yeast selected from the group consisting of: Candida lipolytica, Candida antarctica, Yarrowia lipolytica, especially derived from Candida lipolytica. As used herein, "source" means the original origin of expression of the lipase gene. For example, a lipase obtained by expressing a lipase gene from an organism A in an organism B is considered to be derived from the organism A in the present invention. For example, the lipase of the present invention may be derived from one or more of Candida lipolytica, Candida antarctica, Yarrow lipolytica, Pseudomonas fluorescens and the like. In one embodiment, the lipase of the invention is derived from Candida lipolytica. Lipases from these and many other organisms are known in the art and methods for their preparation can be found in many literatures and are within the purview of those skilled in the art.
在一个实施方案中,所述脂肪酶可以是游离的脂肪酶或固定化的脂肪酶。In one embodiment, the lipase may be free lipase or immobilized lipase.
作为游离形式的脂肪酶,可以使用分离的脂肪酶,也可以使用未分离的脂肪酶。分离的脂肪酶是指除去了初始存在环境中部分或全部污染物的脂肪酶,包括但不限于经不同程度纯化的脂肪酶。未分离的脂肪酶是指存在于初始环境中的脂肪酶,包括但不限于含脂肪酶的发酵液及发酵液上清。As the lipase in free form, either isolated lipase or unisolated lipase may be used. Isolated lipase refers to lipase from which some or all of the contaminants in the original environment have been removed, including but not limited to lipase purified to varying degrees. Unisolated lipase refers to lipase present in the initial environment, including but not limited to lipase-containing fermentation broth and fermentation broth supernatant.
在一个优选的实施方案中,所述脂肪酶是固定化脂肪酶。In a preferred embodiment, said lipase is an immobilized lipase.
可以使用本领域已知的方法固定化脂肪酶。例如,可以使用以下两种方法中任一种来制备本发明的固定化脂肪酶:(A)将载体和共固定剂按质量体积比1∶1-1∶3的范围混合,室温晾干得到活化载体;共固定剂为PEG6000、椰子油、吐温80、明胶、卵磷脂和硫酸镁混合物,其质量比为明胶∶卵磷脂∶PEG6000∶吐温80∶硫酸镁∶椰子油=5∶1∶1∶2∶1∶1,镁盐为氯化镁或硫酸镁;用脂肪酶的水溶液按1000-30000单位/克活化载体与活化载体浸泡、混合、室温晾干,制得酶活为约8000IU/g的固定化脂肪酶;或者(B)用脂肪酶的发酵液或发酵液上清将载体浸泡、混合,室温晾干,制得酶活为8000IU/g的固定化脂肪酶。本发明中脂肪酶的酶活定义为:在40℃条件下,pH8.0的磷酸缓冲溶液中水解橄榄油,每分钟释放出1μmol脂肪酸的酶量为一个酶活单位。本发明在制备固定化脂肪酶时,可以制成约8000IU/g载体的水平,当然也可以其它酶活水平制备固定化脂肪酶。这是本领域技术人员的公知常识。Lipase can be immobilized using methods known in the art. For example, any one of the following two methods can be used to prepare the immobilized lipase of the present invention: (A) mix the carrier and co-immobilizer in the range of mass volume ratio 1:1-1:3, and dry at room temperature to obtain Activated carrier; co-fixative is PEG6000, coconut oil, Tween 80, gelatin, lecithin and magnesium sulfate mixture, and its mass ratio is gelatin: lecithin: PEG6000: Tween 80: magnesium sulfate: coconut oil=5: 1: 1:2:1:1, the magnesium salt is magnesium chloride or magnesium sulfate; the aqueous solution of lipase is used to soak the activated carrier and the activated carrier at 1000-30000 units/g, mix, and dry at room temperature to obtain an enzyme activity of about 8000IU/g or (B) soak the carrier with lipase fermentation broth or fermentation broth supernatant, mix, and dry at room temperature to obtain an immobilized lipase with an enzyme activity of 8000 IU/g. The enzymatic activity of lipase in the present invention is defined as: under the condition of 40 DEG C, the enzyme amount of hydrolyzing olive oil in a phosphate buffer solution of pH 8.0 and releasing 1 μmol of fatty acid per minute is an enzyme activity unit. When preparing the immobilized lipase in the present invention, the level of about 8000 IU/g carrier can be prepared, and of course other enzyme activity levels can also be used to prepare the immobilized lipase. This is common knowledge of those skilled in the art.
此外,本发明固定化酶的制备可参见本申请人的共同待审中国发明专利申请No.200510112638.5。另外,在下列文献中也教导了在本发明中使用的粗酶、固定化酶、修饰酶以及酶的发酵液等的制备:Tan TW,Zhang M,Wang BW,Ying CH,Deng L.Screening of high lipaseproducing Candida sp.and production of lipase by fermentation.Process Biochem 2003,39(4):459-65;Mingrui Yu,Shaowei Qin,TianweiTan,Purification and characterization of the extracellular lipase Lip2from Yarrowia lipolytica,Process Biochemistry 42(2007)384-391;KailiNie,Feng Xie,Fang Wang,Tianwei Tan,Lipase catalyzed methanolysisto produce biodiesel:Optimization of the biodiesel production.Journalof Molecular Catalysis B:Enzymatic 43(2006)142-147;以及中国发明专利申请号02117614.0,其公开号为CN1456674;Mingrui Yu,StefanLange,Sven Richter,Tianwei Tan,Rolf D.Schmid High~levelexpression of extracellular lipase Lip2 from Yarrowia lipolytica inPichia pastoris and its purification and characterization.ProteinExpression and Purification 53(2007)255-263。上述文献的内容均通过引用全文并入本文。In addition, the preparation of the immobilized enzyme of the present invention can be referred to the applicant's co-pending Chinese invention patent application No. 200510112638.5. In addition, the preparation of fermented liquid of crude enzyme, immobilized enzyme, modified enzyme and enzyme used in the present invention is also taught in the following documents: Tan TW, Zhang M, Wang BW, Ying CH, Deng L.Screening of high lipaseproducing Candida sp. and production of lipase by fermentation. Process Biochem 2003, 39(4): 459-65; Mingrui Yu, Shaowei Qin, Tianwei Tan, Purification and characterization of the extracellular lipase Lip2from Yarrowia0 lipolytica 2Biolytica, 384-391; KailiNie, Feng Xie, Fang Wang, Tianwei Tan, Lipase catalyzed methanolysis to produce biodiesel: Optimization of the biodiesel production. Journal of Molecular Catalysis B: Enzymatic 43(2006) 142-147; The publication number is CN1456674; Mingrui Yu, StefanLange, Sven Richter, Tianwei Tan, Rolf D.Schmid High~levelexpression of extracellular lipase Lip2 from Yarrowia lipolytica inPichia pastoris and its purification and characterization. ProteinExpression-5(3250-5) The contents of the above documents are all incorporated herein by reference in their entirety.
此外,本领域技术人员将理解,酶的发酵、改造及固定化并不局限于上述文献提供的方法,普通技术人员根据本领域中的一般性知识,可以十分容易地确定合适的酶的生产制备方法。In addition, those skilled in the art will understand that the fermentation, transformation and immobilization of enzymes are not limited to the methods provided in the above documents, and those of ordinary skill can easily determine the production and preparation of suitable enzymes based on general knowledge in the art. method.
在本发明脂肪酶的固定化中,可以采用任何合适的载体。所述载体可以是例如固体颗粒,如硅胶、硅藻土或分子筛,优选硅胶。或者,所述载体可以是膜状织物或非织造布,例如天然纤维织物如棉布或化学纤维织物如聚酯织物,尤其是膜状织物,优选为棉、尼龙、丝绸、聚酯或纤维素的织物,其具有表面积大、吸附性强、价格便宜、稳定性好以及可以重复利用的特点。In the immobilization of the lipase of the present invention, any suitable carrier can be used. The support can be, for example, solid particles such as silica gel, diatomaceous earth or molecular sieves, preferably silica gel. Alternatively, the carrier can be a film-like fabric or a non-woven fabric, such as a natural fiber fabric such as cotton or a chemical fiber fabric such as a polyester fabric, especially a film-like fabric, preferably cotton, nylon, silk, polyester or cellulose. The fabric has the characteristics of large surface area, strong adsorption, low price, good stability and reusability.
所用的载体硅藻土和树脂也是公知的常用载体,织物膜是市场上销售的织物。本发明所用的发酵液例如可以是酵母类脂肪酶发酵液,用市售的或自制备的均可。例如:采用解脂假丝酵母发酵制备,发酵条件可以是温度26℃、pH自然、搅拌转速为300rpm、通气量为1VVM,培养基组成可以是:有机氮源、有机碳源、无机盐等组成。The used carrier diatomaceous earth and resin are also known and commonly used carriers, and the fabric membrane is a commercially available fabric. The fermented liquid used in the present invention can be, for example, yeast-based lipase fermented liquid, either commercially available or self-prepared. For example: using Candida lipolytica for fermentation, the fermentation conditions can be temperature 26°C, pH natural, stirring speed 300rpm, ventilation volume 1VVM, medium composition can be: organic nitrogen source, organic carbon source, inorganic salt, etc. .
在一个实施方案中,本发明织物膜的固定化脂肪酶可用于搅拌槽式反应器,将固定化脂肪酶固定在圆柱形网架上,网架固定在转轴上一并作为搅拌桨作轴向旋转。作为替代,也可以本领域已知的其它方式使用固定化脂肪酶。In one embodiment, the immobilized lipase of the fabric membrane of the present invention can be used in a stirred tank reactor, and the immobilized lipase is fixed on a cylindrical grid, and the grid is fixed on a rotating shaft and serves as a stirring paddle for the axial direction. rotate. Alternatively, immobilized lipases may also be used in other ways known in the art.
在一个实施方案中,本发明织物膜的固定化脂肪酶可用于固定床式反应器,将固定化脂肪酶固定在圆柱形网架上,圆柱形网架固定在反应器中。作为替代,也可以本领域已知的其它方式使用固定化脂肪酶。In one embodiment, the immobilized lipase on the fabric membrane of the present invention can be used in a fixed bed reactor, and the immobilized lipase is fixed on a cylindrical grid, and the cylindrical grid is fixed in the reactor. Alternatively, immobilized lipases may also be used in other ways known in the art.
在本发明的方法中,所述脂肪酸可以选自:脂肪酸、及其混合物。所述脂肪酸可以选自C4-C30脂肪酸,C5-C26脂肪酸,C6-C24脂肪酸,C6-C20脂肪酸,C8-C18脂肪酸,C8-C16脂肪酸,C10-C18脂肪酸,C10-C16脂肪酸,C12-C16脂肪酸,及其混合物。比如其可以是月桂酸、肉豆蔻酸、棕榈酸、硬脂酸等,或其混合物。在本发明中,所述脂肪酸可以是饱和或不饱和脂肪酸,优选饱和脂肪酸。In the method of the present invention, the fatty acid may be selected from: fatty acids, and mixtures thereof. The fatty acid can be selected from C4-C30 fatty acid, C5-C26 fatty acid, C6-C24 fatty acid, C6-C20 fatty acid, C8-C18 fatty acid, C8-C16 fatty acid, C10-C18 fatty acid, C10-C16 fatty acid, C12-C16 fatty acid , and mixtures thereof. For example, it may be lauric acid, myristic acid, palmitic acid, stearic acid, etc., or a mixture thereof. In the present invention, the fatty acid may be saturated or unsaturated fatty acid, preferably saturated fatty acid.
在一个实施方案中,所述脂肪酸可以是动物/植物油脂水解产生的脂肪酸混合物或分离的脂肪酸。In one embodiment, the fatty acid may be a mixture of fatty acids or isolated fatty acids produced by hydrolysis of animal/vegetable oils and fats.
在一个优选实施方案中,所述脂肪酸是棕榈酸。In a preferred embodiment, the fatty acid is palmitic acid.
在一个方面,本发明制备维生素A脂肪酸酯的反应在非水相体系中进行。这种非水相体系是本领域技术人员已知的。例如,所述非水相体系可以是有机溶剂,或者还可以是离子液体。本文所述的离子液体是指由带正电离子和带负电离子构成并且在-100℃至200℃之间均呈液体状态的物质。理论上在离子液体中没有电中性的分子,而全部是阴离子和阳离子。In one aspect, the reaction of the present invention for preparing vitamin A fatty acid ester is carried out in a non-aqueous phase system. Such non-aqueous systems are known to those skilled in the art. For example, the non-aqueous phase system may be an organic solvent, or may also be an ionic liquid. The ionic liquid described herein refers to a substance that is composed of positively charged ions and negatively charged ions and is in a liquid state between -100°C and 200°C. Theoretically, there are no electrically neutral molecules in ionic liquids, but all anions and cations.
在非水相体系中的酶催化作用优于水中的酶。有机溶剂能保持较低的水分活度,可以降低酯化和水解反应的热力学和动力学障碍。而且有机底物在有机溶剂中具有较高的溶解度从而可以提高反应速度。因此,在非水体系中的酯化反应可实现高转化率,简化分离工艺。Enzyme catalysis in non-aqueous systems is superior to that in water. Organic solvents can maintain low water activity, which can reduce the thermodynamic and kinetic barriers of esterification and hydrolysis reactions. Moreover, organic substrates have higher solubility in organic solvents, which can increase the reaction rate. Therefore, the esterification reaction in a non-aqueous system can achieve high conversion and simplify the separation process.
在一个实施方案中,所述有机溶剂可以是芳香烃及其衍生物、卤代烷烃及其衍生物、直链和支链烷烃、环烷烃等、或其混合物。例如,所述有机溶剂是苯、甲苯、二甲苯、氯甲烷、二氯甲烷、三氯甲烷、四氯甲烷、氯乙烷、二氯乙烷、正己烷、正庚烷、正辛烷、正癸烷、环己烷、石油醚等、或其混合物。在一个优选实施方案中,所述有机溶剂是正己烷或石油醚。石油醚是从石油分馏而得的物质,按分馏沸程可以分成30-60、60-90等不同类型,其主要成分是戊烷和己烷等低级脂肪族烷烃。In one embodiment, the organic solvent may be aromatic hydrocarbons and their derivatives, halogenated alkanes and their derivatives, linear and branched alkanes, cycloalkanes, etc., or mixtures thereof. For example, the organic solvent is benzene, toluene, xylene, methyl chloride, methylene chloride, chloroform, tetrachloromethane, ethyl chloride, ethylene dichloride, n-hexane, n-heptane, n-octane, n- Decane, cyclohexane, petroleum ether, etc., or a mixture thereof. In a preferred embodiment, the organic solvent is n-hexane or petroleum ether. Petroleum ether is a substance obtained by fractionation of petroleum. According to the fractionation boiling range, it can be divided into different types such as 30-60 and 60-90. Its main components are lower aliphatic alkanes such as pentane and hexane.
在一些实施方案中,本发明的非水相体系可以含水或者不含水。例如,所述非水相体系的含水量可以是0-10%,优选0-5%,更优选0-2%,最优选0-1%。In some embodiments, the non-aqueous systems of the present invention may or may not contain water. For example, the water content of the non-aqueous phase system may be 0-10%, preferably 0-5%, more preferably 0-2%, most preferably 0-1%.
在一个优选实施方案中,所述有机溶剂是含水量0-1%的石油醚。例如,可以是含水量为0、0.1%、0.2%、0.3%、0.4%、0.5%、0.6%、0.7%、0.8%、0.9%、1.0%的石油醚。In a preferred embodiment, the organic solvent is petroleum ether with a water content of 0-1%. For example, it may be petroleum ether with a water content of 0, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%.
在一个方面,本发明的反应体系中可以加入吸水剂以除去水分,比如硅胶、分子筛、吸水树脂等。本文所述的硅胶是指无机硅胶,其主要由二氧化硅组成,具有很强的吸附能力,是一种常用的色谱分离载体。硅胶根据其孔径的大小可分为大孔硅胶、粗孔硅胶、介孔硅胶、细孔硅胶等。分子筛是一种具有立方晶格的硅铝酸盐化合物,主要由硅铝通过氧桥连接组成空旷的骨架结构,在结构中有很多孔径均匀的孔道和排列整齐、内表面积很大的空穴。这些微小的孔穴直径大小均匀,能把比孔道直径小的分子吸附到孔穴的内部中来,而把比孔道大得分子排斥在外,因而能把形状直径大小不同的分子,极性程度不同的分子,沸点不同的分子,饱和程度不同的分子分离开来,即具有“筛分”分子的作用,故称为分子筛。分子筛吸湿能力极强,保存时应避免直接暴露在空气中。吸水树脂是指各种具有吸水能力的高分子聚合物,比如聚丙烯酸、纤维素及其衍生物等。In one aspect, a water-absorbing agent can be added to the reaction system of the present invention to remove water, such as silica gel, molecular sieve, water-absorbing resin, and the like. The silica gel mentioned in this article refers to inorganic silica gel, which is mainly composed of silicon dioxide, has strong adsorption capacity, and is a commonly used chromatographic separation carrier. Silica gel can be divided into macroporous silica gel, coarse-porous silica gel, mesoporous silica gel, and fine-pore silica gel according to its pore size. Molecular sieve is a kind of aluminosilicate compound with cubic lattice. It is mainly composed of silicon and aluminum connected by oxygen bridges to form a hollow skeleton structure. These tiny pores have uniform diameters, which can adsorb molecules smaller than the diameter of the pores into the interior of the pores, while repelling molecules larger than the pores, so that molecules with different shapes and diameters, and molecules with different degrees of polarity can be absorbed. , Molecules with different boiling points and molecules with different degrees of saturation are separated, that is, they have the function of "sieving" molecules, so they are called molecular sieves. Molecular sieves have strong hygroscopicity, so they should avoid direct exposure to air during storage. Water-absorbent resin refers to various polymers with water-absorbing capacity, such as polyacrylic acid, cellulose and its derivatives.
在本发明的维生素A脂肪酸酯制备反应中,维生素A和脂肪酸的摩尔比可以是任意可用的比例,例如考虑到原料成本而优选不超过1∶1。在一个实施方案中,维生素A和脂肪酸的摩尔比可以在1∶1-1∶5的范围,例如在1∶1-1∶3的范围。但是在本发明中,维生素A和脂肪酸的摩尔比并不限于该范围,例如其摩尔比可以大于1∶1或者小于1∶5。在本发明的方法中,1∶1以及甚至更高摩尔比的维生素A和脂肪酸仍然可以得到优异的维生素A转化率。比如,在实施例2中,1∶1摩尔比的维生素A和棕榈酸得到90%的维生素A转化率。In the preparation reaction of vitamin A fatty acid ester of the present invention, the molar ratio of vitamin A and fatty acid can be any available ratio, for example, it is preferably not more than 1:1 in consideration of raw material cost. In one embodiment, the molar ratio of vitamin A and fatty acid may be in the range of 1:1-1:5, for example in the range of 1:1-1:3. However, in the present invention, the molar ratio of vitamin A and fatty acid is not limited to this range, for example, the molar ratio may be greater than 1:1 or less than 1:5. In the method of the present invention, a 1:1 and even higher molar ratio of vitamin A and fatty acid can still give excellent vitamin A conversion. For example, in Example 2, a 1:1 molar ratio of vitamin A and palmitic acid resulted in a vitamin A conversion of 90%.
在本发明的维生素A脂肪酸酯制备反应中,脂肪酶的用量可以是任意合适的量。脂肪酶的用量与多种因素相关,这些因素包括但不限于维生素A的量和浓度、脂肪酸的量和浓度、两种底物的摩尔比、反应体系、反应温度、反应时间、脂肪酶自身的比活性、脂肪酶来源等。在一个实施方案中,固定化脂肪酶的用量是维生素A质量的0.2-5倍。例如,可以是0.2倍、0.3倍、0.4倍、0.5倍、0.8倍、1倍、2倍、3倍、4倍、5倍以及其间的任何比例。在一个具体实施方案中,固定化脂肪酶的用量不限于此。In the preparation reaction of vitamin A fatty acid ester of the present invention, the amount of lipase can be any suitable amount. The amount of lipase is related to many factors, these factors include but not limited to the amount and concentration of vitamin A, the amount and concentration of fatty acids, the molar ratio of the two substrates, reaction system, reaction temperature, reaction time, lipase itself Specific activity, source of lipase, etc. In one embodiment, the amount of immobilized lipase is 0.2-5 times the mass of vitamin A. For example, it may be 0.2 times, 0.3 times, 0.4 times, 0.5 times, 0.8 times, 1 times, 2 times, 3 times, 4 times, 5 times and any ratio therebetween. In a specific embodiment, the amount of immobilized lipase is not limited thereto.
在本发明维生素A脂肪酸酯的制备反应体系中,其反应温度可以是能进行反应的任何温度。最适反应温度与具体的反应条件有关,比如脂肪酶来源、脂肪酶浓度、底物类型、有机溶剂、反应时间等。例如,反应温度可以是20-50℃,25-45℃,30-40℃,30-37℃等。在一个具体实施方案中,反应温度可以是15℃,20℃,25℃,30℃,35℃,37℃,40℃,45℃,50℃等,例如是30℃。在反应期间,反应温度可以保持恒定,或者按照一定规律变化。一般来说,在反应期间保持反应温度恒定。In the preparation reaction system of vitamin A fatty acid ester of the present invention, its reaction temperature can be any temperature that can carry out reaction. The optimum reaction temperature is related to specific reaction conditions, such as lipase source, lipase concentration, substrate type, organic solvent, reaction time, etc. For example, the reaction temperature may be 20-50°C, 25-45°C, 30-40°C, 30-37°C, etc. In a specific embodiment, the reaction temperature may be 15°C, 20°C, 25°C, 30°C, 35°C, 37°C, 40°C, 45°C, 50°C, etc., for example 30°C. During the reaction, the reaction temperature can be kept constant or changed according to certain rules. In general, the reaction temperature is kept constant during the reaction.
在本发明维生素A脂肪酸酯的制备反应体系中,其反应时间可以是能进行反应的任何时间长度,这可以根据实际需要来设定。对于期望达到的转化率和其它期望效果,具体的反应时间与多种反应条件有关,比如脂肪酶来源、脂肪酶的量和浓度、底物类型和底物量、有机溶剂等。例如,反应时间可以是1分钟-1周,5分钟-2天,或10分钟-1天等。在一个具体实施方案中,反应时间可以是1分钟,2分钟,3分钟,4分钟,5分钟,6分钟,7分钟,8分钟,9分钟,10分钟,15分钟,20分钟,30分钟,40分钟,50分钟,1小时,2小时,3小时,4小时,5小时,6小时,7小时,8小时,9小时,10小时,12小时,15小时,18小时,20小时,24小时,2天,3天,4天,5天,6天,或7天等。In the reaction system for the preparation of vitamin A fatty acid ester of the present invention, the reaction time can be any length of time that can carry out the reaction, which can be set according to actual needs. For the expected conversion rate and other desired effects, the specific reaction time is related to various reaction conditions, such as the source of lipase, the amount and concentration of lipase, the type and amount of substrate, organic solvent and so on. For example, the reaction time can be 1 minute to 1 week, 5 minutes to 2 days, or 10 minutes to 1 day, etc. In a specific embodiment, the reaction time can be 1 minute, 2 minutes, 3 minutes, 4 minutes, 5 minutes, 6 minutes, 7 minutes, 8 minutes, 9 minutes, 10 minutes, 15 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 12 hours, 15 hours, 18 hours, 20 hours, 24 hours , 2 days, 3 days, 4 days, 5 days, 6 days, or 7 days etc.
在一个方面,本发明提供一种在非水相体系中用固定化脂肪酶催化维生素A和脂肪酸反应来制备维生素A脂肪酸酯的方法。In one aspect, the present invention provides a method for preparing vitamin A fatty acid ester by using immobilized lipase to catalyze the reaction between vitamin A and fatty acid in a non-aqueous phase system.
在一个实施方案中,将底物维生素A和脂肪酸,按摩尔比在1∶1-1∶5的范围,与有机溶剂和固定化脂肪酶混合,固定化脂肪酶的用量是维生素A质量的0.3-5倍,在20-50℃的条件下,反应1-24小时,取出固定化脂肪酶,反应液经过分离、结晶得到维生素A脂肪酸酯;有机溶剂是含水量为0-1%的石油醚;固定化脂肪酶是固定在载体上的酵母类脂肪酶,例如:解脂假丝酵母脂肪酶、南极假丝酵母脂肪酶等。In one embodiment, the substrate vitamin A and fatty acid are mixed with organic solvent and immobilized lipase in a molar ratio of 1:1-1:5, and the amount of immobilized lipase is 0.3% of vitamin A quality. -5 times, under the condition of 20-50°C, react for 1-24 hours, take out the immobilized lipase, and the reaction solution is separated and crystallized to obtain vitamin A fatty acid ester; the organic solvent is petroleum with a water content of 0-1%. Ether; immobilized lipase is a yeast lipase immobilized on a carrier, for example: Candida lipolytica lipase, Candida antarctica lipase, etc.
由本发明得到的产品色泽浅,品质高,成本低。为脂肪酸酯的工业化生产提供了一种新方法。The product obtained by the invention has light color, high quality and low cost. A new method is provided for the industrial production of fatty acid esters.
本发明与传统的化学合成法相比,本发明的方法反应条件温和、能耗低,大大降低了生产成本。同时本发明使用生物催化剂,反应特异性强、副产物少。产品具有色泽浅、品质高的特点。Compared with the traditional chemical synthesis method, the method of the invention has mild reaction conditions, low energy consumption, and greatly reduces the production cost. Simultaneously, the invention uses a biocatalyst, which has strong reaction specificity and few by-products. The product has the characteristics of light color and high quality.
本发明与使用维生素A醋酸酯作底物的合成方法相比,具有以下优点:1、有更高的转化率;2、反应时间缩短;3、脂肪酶比如固定化酶可以重复使用,从而其使用寿命延长;4、维生素A与脂肪酸的摩尔比可以更小,减少过量脂肪酸的量。Compared with the synthetic method using vitamin A acetate as substrate, the present invention has the following advantages: 1, higher conversion rate is arranged; 2, the reaction time is shortened; 3, lipase such as immobilized enzyme can be reused, thereby its 4. The molar ratio of vitamin A and fatty acid can be smaller, reducing the amount of excess fatty acid.
实施例Example
下面将结合一些具体实施例来进一步描述本发明。需要注意的是,这些具体实施例只是作为举例说明,而不应理解为对本发明要求保护范围的限制。此外,还提供了比较实施例,以进一步举例说明本发明相对于当前所用方法的优点。The present invention will be further described below in conjunction with some specific embodiments. It should be noted that these specific examples are only for illustration, and should not be construed as limiting the protection scope of the present invention. In addition, comparative examples are provided to further illustrate the advantages of the present invention over currently used methods.
本发明实施例中所用脂肪酶是参考申请人的中国发明专利申请No.200510112638.5以及Tan TW,Zhang M,Wang BW,Ying CH,Deng L.Screening of high lipase producing Candida sp.and production of lipaseby fermentation.Process Biochem 2003;39(4):459-65中的方法制备的。The lipase used in the embodiments of the present invention refers to the applicant's Chinese invention patent application No. 200510112638.5 and Tan TW, Zhang M, Wang BW, Ying CH, Deng L. Screening of high lipase producing Candida sp. and production of lipase by fermentation. Prepared by the method in Process Biochem 2003; 39(4): 459-65.
根据以下方法计算维生素A的转化率。首先对反应中生成的维生素A棕榈酸酯进行HPLC分析,色谱条件如下:色谱柱为Alltech C18(250×4.6mm,4.5μm);流动相为100%甲醇;检测器为岛津10A紫外检测器;检测波长327nm;流速1ml/min。用维生素A棕榈酸酯标准品制作标准曲线,根据标准曲线用外标法计算生成维生素A棕榈酸酯的质量,然后根据以下方程计算维生素A的转化率:The conversion rate of vitamin A was calculated according to the following method. First, the vitamin A palmitate generated in the reaction is analyzed by HPLC, and the chromatographic conditions are as follows: the chromatographic column is Alltech C18 (250 × 4.6mm, 4.5 μm); the mobile phase is 100% methanol; the detector is Shimadzu 10A UV detector ; Detection wavelength 327nm; Flow rate 1ml/min. Make a standard curve with the vitamin A palmitate standard substance, calculate the quality of generating vitamin A palmitate with the external standard method according to the standard curve, then calculate the conversion rate of vitamin A according to the following equation:
维生素A的转化率=(m/M)/(m0/M0)×100%Conversion rate of vitamin A = (m/M)/(m 0 /M 0 )×100%
其中,m为生成维生素A棕榈酸酯的质量(g);M为维生素A棕榈酸酯的分子量524.9(g/mol);m0为底物维生素A的质量(g);M0为维生素A的分子量328.4(g/mol)。Wherein, m is the quality (g) that generates vitamin A palmitate; M is the molecular weight 524.9 (g/mol) of vitamin A palmitate; m 0 is the quality (g) of substrate vitamin A; M 0 is vitamin A The molecular weight is 328.4 (g/mol).
实施例1:Example 1:
1.脂肪酶的固定化1. Immobilization of Lipase
棉布和共固定剂按质量体积比1∶1的比例混合(W∶V),室温晾干,得到活化载体;共固定剂为PEG6000、椰子油、吐温80、明胶、卵磷脂和硫酸镁混合物,其质量比为明胶∶卵磷脂∶PEG6000∶吐温80∶硫酸镁∶椰子油=5∶1∶1∶2∶1∶1。用解脂假丝酵母脂肪酶的发酵液按8000IU/g活化载体的比例与活化载体浸泡、混合、室温晾干,制得酶活为8000IU/g的固定化脂肪酶。Cotton cloth and co-fixative were mixed according to the mass volume ratio of 1:1 (W:V), and dried at room temperature to obtain activated carrier; co-fixative was a mixture of PEG6000, coconut oil, Tween 80, gelatin, lecithin and magnesium sulfate , its mass ratio is gelatin: lecithin: PEG6000: Tween 80: magnesium sulfate: coconut oil=5: 1: 1: 2: 1: 1. The fermented liquid of candida lipolytica lipase is soaked with the activated carrier at the ratio of 8000IU/g activated carrier, mixed and dried at room temperature to prepare the immobilized lipase with an enzyme activity of 8000IU/g.
2.催化合成维生素A棕榈酸酯2. Catalytic synthesis of vitamin A palmitate
将底物0.160g(0.56mmol)维生素A和0.429g(1.68mmol)棕榈酸与10ml含水量为0.5%的石油醚溶剂和0.3g固定化脂肪酶混合,加入0.5g硅胶,在温度30℃的条件下,摇床中(190r/min),反应8小时,转化率为95%;将反应液除去固定化脂肪酶、硅胶,减压蒸发除去溶剂石油醚,得到粗品维生素A棕榈酸酯,再用甲醇在30℃下多次洗涤粗品维生素A棕榈酸酯,离心,弃去上清液,经真空干燥后得到纯化的维生素A棕榈酸酯,进一步结晶得到浅黄色维生素A棕榈酸酯晶体。Substrate 0.160g (0.56mmol) vitamin A and 0.429g (1.68mmol) palmitic acid and 10ml water content are 0.5% sherwood oil solvent and 0.3g immobilized lipase mixing, add 0.5g silica gel, at temperature 30 ℃ Under conditions, in a shaker (190r/min), reacted for 8 hours, and the conversion rate was 95%; the reaction liquid was removed from immobilized lipase and silica gel, and the solvent petroleum ether was evaporated under reduced pressure to obtain the crude product vitamin A palmitate, and then Wash the crude vitamin A palmitate several times with methanol at 30°C, centrifuge, discard the supernatant, and obtain purified vitamin A palmitate after vacuum drying, and further crystallize to obtain light yellow vitamin A palmitate crystals.
实施例2:Example 2:
操作步骤同实施例1,不同之处在于:0.429g(1.68mmol)棕榈酸改为0.143g(0.56mmol),底物摩尔比(维生素A/棕榈酸)为1∶1;转化率为93%。The operation steps are the same as in Example 1, except that: 0.429g (1.68mmol) palmitic acid is changed to 0.143g (0.56mmol), and the substrate molar ratio (vitamin A/palmitic acid) is 1: 1; conversion rate is 93% .
实施例3:Example 3:
操作步骤同实施例1,不同之处在于:0.429g(1.68mmol)棕榈酸改为0.286g(1.12mmol),底物摩尔比(维生素A/棕榈酸)为1∶2;转化率为93%。The operating steps are the same as in Example 1, except that: 0.429g (1.68mmol) palmitic acid is changed to 0.286g (1.12mmol), and the substrate molar ratio (vitamin A/palmitic acid) is 1: 2; the conversion rate is 93% .
实施例4:Example 4:
0.429g(1.68mmol)棕榈酸改为0.527g(2.24mmol),底物摩尔比(维生素A/棕榈酸)为1∶4;转化率为94%。0.429g (1.68mmol) of palmitic acid was changed to 0.527g (2.24mmol), and the substrate molar ratio (vitamin A/palmitic acid) was 1:4; the conversion rate was 94%.
实施例5:Example 5:
操作步骤同实施例1,不同之处在于:0.429g(1.68mmol)棕榈酸改为0.715g(2.8mmol),底物摩尔比(维生素A/棕榈酸)为1∶5;转化率为95%。The operating steps are the same as in Example 1, except that: 0.429g (1.68mmol) palmitic acid is changed to 0.715g (2.8mmol), and the substrate molar ratio (vitamin A/palmitic acid) is 1: 5; conversion rate is 95% .
实施例6:Embodiment 6:
操作步骤同实施例1,不同之处在于:0.3g固定化脂肪酶改为0.05g固定化脂肪酶;转化率为91.5%。The operation steps are the same as in Example 1, except that 0.3 g of immobilized lipase is changed to 0.05 g of immobilized lipase; the conversion rate is 91.5%.
实施例7:Embodiment 7:
操作步骤同实施例1,不同之处在于:0.3g固定化脂肪酶改为0.1g固定化脂肪酶;转化率为94%。The operation steps are the same as in Example 1, except that 0.3 g of immobilized lipase is changed to 0.1 g of immobilized lipase; the conversion rate is 94%.
实施例8:Embodiment 8:
操作步骤同实施例1,不同之处在于:0.3g固定化脂肪酶改为0.2g固定化脂肪酶;转化率为95%。The operation steps are the same as in Example 1, except that 0.3 g of immobilized lipase is changed to 0.2 g of immobilized lipase; the conversion rate is 95%.
实施例9:Embodiment 9:
操作步骤同实施例1,不同之处在于:0.3g固定化脂肪酶改为0.4g固定化脂肪酶;转化率为95%。The operation steps are the same as in Example 1, except that 0.3 g of immobilized lipase is changed to 0.4 g of immobilized lipase; the conversion rate is 95%.
实施例10:Example 10:
操作步骤同实施例1,不同之处在于:0.3g固定化脂肪酶改为0.5g固定化脂肪酶;转化率为95%。The operation steps are the same as in Example 1, except that 0.3 g of immobilized lipase is changed to 0.5 g of immobilized lipase; the conversion rate is 95%.
实施例11:Example 11:
操作步骤同实施例1,不同之处在于:温度30℃改为温度25℃;转化率为93%。The operation steps are the same as in Example 1, except that the temperature is changed from 30° C. to 25° C.; the conversion rate is 93%.
实施例12:Example 12:
操作步骤同实施例1,不同之处在于:温度30℃改为温度40℃;转化率为89%。The operation steps are the same as in Example 1, except that the temperature is changed from 30° C. to 40° C.; the conversion rate is 89%.
实施例13:Example 13:
操作步骤同实施例1,不同之处在于:温度30℃改为温度50℃;转化率为78%。The operation steps are the same as in Example 1, except that the temperature is changed from 30° C. to 50° C.; the conversion rate is 78%.
实施例14:Example 14:
操作步骤同实施例1,不同之处在于:反应时间8h改为反应时间0.5h;转化率为94.7%。The operation steps are the same as in Example 1, except that the reaction time is changed from 8h to 0.5h; the conversion rate is 94.7%.
实施例15:Example 15:
操作步骤同实施例1,不同之处在于:反应时间8h改为反应时间1h;转化率为96%。The operation steps are the same as in Example 1, except that the reaction time is changed from 8h to 1h; the conversion rate is 96%.
实施例16:Example 16:
操作步骤同实施例1,不同之处在于:反应时间8h改为反应时间2h;转化率为95%。The operation steps are the same as in Example 1, except that the reaction time is changed from 8h to 2h; the conversion rate is 95%.
实施例17:Example 17:
操作步骤同实施例1,不同之处在于:反应时间8h改为反应时间4h;转化率为95%。The operation steps are the same as in Example 1, except that the reaction time is changed from 8h to 4h; the conversion rate is 95%.
实施例18:Example 18:
操作步骤同实施例1,不同之处在于:反应时间8h改为反应时间6h;转化率为94%。The operation steps are the same as in Example 1, except that the reaction time is changed from 8h to 6h; the conversion rate is 94%.
实施例19:Example 19:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为加0.3g硅胶;转化率为94%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to 0.3 g of silica gel; the conversion rate is 94%.
实施例20:Example 20:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为加0.8g硅胶;转化率为95%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to 0.8 g of silica gel; the conversion rate is 95%.
实施例21:Example 21:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶;转化率为91%。The operation steps are the same as those in Example 1, except that 0.5 g of silica gel is added instead of silica gel; the conversion rate is 91%.
实施例22:Example 22:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,0.3g固定化脂肪酶改为0.05g固定化脂肪酶;转化率为61.5%。The operation steps are the same as those in Example 1, except that: instead of adding 0.5 g of silica gel, 0.3 g of immobilized lipase is replaced by 0.05 g of immobilized lipase; the conversion rate is 61.5%.
实施例23:Example 23:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,0.3g固定化脂肪酶改为0.1g固定化脂肪酶;转化率为74.2%。The operation steps are the same as those in Example 1, except that: instead of adding 0.5 g of silica gel, 0.3 g of immobilized lipase is replaced by 0.1 g of immobilized lipase; the conversion rate is 74.2%.
实施例24:Example 24:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,0.3g固定化脂肪酶改为0.2g固定化脂肪酶;转化率为86%。The operation steps are the same as those in Example 1, except that: instead of adding 0.5 g of silica gel, 0.3 g of immobilized lipase is replaced by 0.2 g of immobilized lipase; the conversion rate is 86%.
实施例25:Example 25:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,0.3g固定化脂肪酶改为0.4g固定化脂肪酶;转化率为90%。The operation steps are the same as those in Example 1, except that: instead of adding 0.5 g of silica gel, 0.3 g of immobilized lipase is replaced by 0.4 g of immobilized lipase; the conversion rate is 90%.
实施例26:Example 26:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,反应时间8h改为反应时间0.5h;转化率为70%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to no addition of silica gel, and the reaction time of 8 h is changed to 0.5 h; the conversion rate is 70%.
实施例27:Example 27:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,反应时间8h改为反应时间1h;转化率为84%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to no addition of silica gel, and the reaction time of 8 hours is changed to 1 hour; the conversion rate is 84%.
实施例28:Example 28:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,反应时间8h改为反应时间2h;转化率为90%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to no addition of silica gel, and the reaction time of 8 hours is changed to 2 hours; the conversion rate is 90%.
实施例29:Example 29:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,反应时间8h改为反应时间4h;转化率为90%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to no addition of silica gel, and the reaction time of 8 hours is changed to 4 hours; the conversion rate is 90%.
实施例30:Example 30:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,反应时间8h改为反应时间6h;转化率为91%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to no addition of silica gel, and the reaction time of 8 hours is changed to 6 hours; the conversion rate is 91%.
实施例31:Example 31:
操作步骤同实施例1,不同之处在于:加入0.5g硅胶改为不加硅胶,反应时间8h改为反应时间1h;转化率为84%。The operation steps are the same as those in Example 1, except that the addition of 0.5 g of silica gel is changed to no addition of silica gel, and the reaction time of 8 hours is changed to 1 hour; the conversion rate is 84%.
实施例32:Example 32:
将解脂假丝酵母脂肪酶的发酵液按实施例1的方法固定化,制得酶活为8000IU/g的固定化脂肪酶;再将底物0.160g(0.56mmol)维生素A和0.429g(1.68mmol)棕榈酸与10ml含水量为0.5%的石油醚溶剂和1g固定化脂肪酶混合,加入0.8g硅胶,在温度30℃的条件下,摇床中(190r/min),反应4小时,转化率为95%;取出固定化脂肪酶,晾干放入新的上述反应体系中,反应4小时,转化率为96%;重复上述操作50次,转化率一直保持92%以上,即固定化脂肪酶能重复使用50次,而转化率保持92%以上。The fermented liquid of Candida lipolytica lipase is immobilized by the method of embodiment 1, and the immobilized lipase that makes enzyme activity is 8000IU/g; Substrate 0.160g (0.56mmol) vitamin A and 0.429g ( 1.68mmol) of palmitic acid and 10ml water content are 0.5% sherwood oil solvent and 1g immobilized lipase mixing, add 0.8g silica gel, under the condition of temperature 30 ℃, in the shaker (190r/min), react 4 hours, The conversion rate is 95%; take out the immobilized lipase, dry it and put it into the new above-mentioned reaction system, react for 4 hours, the conversion rate is 96%; repeat the above operation 50 times, the conversion rate remains above 92% all the time, that is, immobilized lipase The lipase can be reused 50 times, while the conversion rate remains above 92%.
比较实施例1Comparative Example 1
将解脂甲丝酵母脂肪酶的发酵液按实施例1的方法固定化,制得酶活为8000IU/g的固定化脂肪酶;再将底物0.100g(0.3mmol)维生素A醋酸酯和0.234g(0.9mmol)棕榈酸与10ml含水量为0.5%的石油醚溶剂和0.3g固定化脂肪酶混合,在温度30℃的条件下,摇床中(190r/min),反应24小时,转化率为80%;取出固定化脂肪酶,反应液经过分离、结晶得到浅黄色维生素A棕榈酸酯晶体。The fermented liquid of M. lipolytica lipase is immobilized by the method of Example 1, and the obtained enzyme activity is the immobilized lipase of 8000IU/g; Substrate 0.100g (0.3mmol) vitamin A acetate and 0.234 g (0.9mmol) of palmitic acid is mixed with 10ml of petroleum ether solvent with a water content of 0.5% and 0.3g of immobilized lipase, and is reacted in a shaking table (190r/min) at a temperature of 30°C for 24 hours, and the conversion rate 80%; the immobilized lipase was taken out, and the reaction solution was separated and crystallized to obtain light yellow vitamin A palmitate crystals.
比较实施例2Comparative Example 2
操作步骤同比较实施例1,不同之处在于:0.234g棕榈酸改为0.078g,底物摩尔比(维生素A醋酸酯/棕榈酸)1∶1;转化率为49%。The operating steps are the same as in Comparative Example 1, except that 0.234g of palmitic acid is changed to 0.078g, and the substrate molar ratio (vitamin A acetate/palmitic acid) is 1: 1; the conversion rate is 49%.
比较实施例3Comparative Example 3
操作步骤同比较实施例1,不同之处在于:0.234g棕榈酸改为0.156g,底物摩尔比(维生素A醋酸酯/棕榈酸)1∶2;转化率为60%。The operating steps are the same as in Comparative Example 1, except that 0.234g of palmitic acid is changed to 0.156g, and the substrate molar ratio (vitamin A acetate/palmitic acid) is 1:2; the conversion rate is 60%.
比较实施例4Comparative Example 4
操作步骤同比较实施例1,不同之处在于:反应24小时改为反应1小时;转化率为25%。The operation steps are the same as those in Comparative Example 1, except that the reaction time is 1 hour instead of 24 hours; the conversion rate is 25%.
比较实施例5Comparative Example 5
操作步骤同比较实施例1,不同之处在于:反应24小时改为反应3小时;转化率为55%。The operation steps are the same as those in Comparative Example 1, except that the reaction time is 3 hours instead of 24 hours; the conversion rate is 55%.
比较实施例6Comparative Example 6
操作步骤同比较实施例1,不同之处在于:反应24小时改为反应12小时;转化率为79%。The operating steps are the same as in Comparative Example 1, except that the reaction time is 12 hours instead of 24 hours; the conversion rate is 79%.
比较实施例7Comparative Example 7
将解脂假丝酵母脂肪酶的发酵液按实施例1方法固定化,制得酶活为8000IU/g的固定化脂肪酶;再将底物0.100g(0.3mmol)维生素A醋酸酯和0.234g(0.9mmol)棕榈酸与10ml含水量为0.5%的石油醚溶剂和0.3g固定化脂肪酶混合,在温度30℃的条件下,摇床中(190r/min),反应12小时,转化率为80%;取出固定化脂肪酶,晾干放入新的上述反应体系中,反应12小时,转化率为80%;重复上述操作,第5次,转化率为75%;重复上述操作,第6次,转化率60%;重复上述操作,第7次,转化率为55%;重复上述操作,第8次,转化率为45%。The fermented liquid of Candida lipolytica lipase is immobilized by the method of Example 1, and the obtained enzyme activity is 8000IU/g immobilized lipase; then substrate 0.100g (0.3mmol) vitamin A acetate and 0.234g (0.9mmol) palmitic acid and 10ml water content are the sherwood oil solvent of 0.5% and 0.3g immobilized lipase mixing, under the condition of temperature 30 ℃, in the shaker (190r/min), reaction 12 hours, conversion rate 80%; take out the immobilized lipase, dry it and put it into the new above-mentioned reaction system, react for 12 hours, the conversion rate is 80%; repeat the above-mentioned operation, the 5th time, the conversion rate is 75%; repeat the above-mentioned operation, the 6th Repeat the above operation, the 7th time, the conversion rate is 55%; repeat the above operation, the 8th time, the conversion rate is 45%.
本领域一般技术人员可以在了解本发明所公开内容的基础上,对本发明所公开的技术方案进行各种补充、修改、变化和替换等,这些补充、修改、变化和替换等也都在本发明权利要求的保护范围内。Those skilled in the art can make various supplements, modifications, changes and substitutions to the technical solutions disclosed in the present invention on the basis of understanding the disclosed content of the present invention. These supplements, modifications, changes and substitutions are also included in the present invention. within the scope of the claims.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101798080A CN101200740A (en) | 2007-12-18 | 2007-12-18 | A method for preparing vitamin A fatty acid ester catalyzed by lipase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101798080A CN101200740A (en) | 2007-12-18 | 2007-12-18 | A method for preparing vitamin A fatty acid ester catalyzed by lipase |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101200740A true CN101200740A (en) | 2008-06-18 |
Family
ID=39516091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101798080A Pending CN101200740A (en) | 2007-12-18 | 2007-12-18 | A method for preparing vitamin A fatty acid ester catalyzed by lipase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101200740A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102363606A (en) * | 2011-11-03 | 2012-02-29 | 厦门金达威集团股份有限公司 | Method for synthesizing vitamin A palmitate |
CN104673870A (en) * | 2013-11-29 | 2015-06-03 | 上虞新和成生物化工有限公司 | Method for synthesizing vitamin A palmitate by using immobilized esterase E.coli BioH as catalyst |
CN105441521A (en) * | 2014-09-01 | 2016-03-30 | 浙江工业大学 | Synthetic method of vitamin A palmitate |
CN106916804A (en) * | 2017-04-05 | 2017-07-04 | 牡丹江医学院 | A kind of preparation method of vitamin A fatty acid ester synthesis immobilized lipase |
CN107099560A (en) * | 2017-04-24 | 2017-08-29 | 浙江工商大学 | The method and its application of enzyme' s catalysis kojic acid lauric acid monoester in a kind of ionic liquid of microwave radiation technology |
CN109234262A (en) * | 2018-09-17 | 2019-01-18 | 北京化工大学 | A kind of method that carrier granulating technique prepares immobilised enzymes |
CN109777793A (en) * | 2019-03-15 | 2019-05-21 | 常熟理工学院 | A kind of GDSL lipase, genetic engineering bacteria and application thereof |
WO2021056683A1 (en) * | 2019-09-27 | 2021-04-01 | 常熟理工学院 | Strain for producing lipase and application thereof |
CN114214371A (en) * | 2021-12-20 | 2022-03-22 | 源创核新(北京)新材料科技有限公司 | A kind of method of lipase-catalyzed synthesis of glycol carbonate |
CN114854717A (en) * | 2022-05-07 | 2022-08-05 | 万华化学集团股份有限公司 | Lipase, and coding gene and application thereof |
CN114901816A (en) * | 2019-12-30 | 2022-08-12 | 帝斯曼知识产权资产管理有限公司 | Lipase-modified strains |
-
2007
- 2007-12-18 CN CNA2007101798080A patent/CN101200740A/en active Pending
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102363606B (en) * | 2011-11-03 | 2013-06-19 | 厦门金达威集团股份有限公司 | Method for synthesizing vitamin A palmitate |
CN102363606A (en) * | 2011-11-03 | 2012-02-29 | 厦门金达威集团股份有限公司 | Method for synthesizing vitamin A palmitate |
CN104673870A (en) * | 2013-11-29 | 2015-06-03 | 上虞新和成生物化工有限公司 | Method for synthesizing vitamin A palmitate by using immobilized esterase E.coli BioH as catalyst |
CN104673870B (en) * | 2013-11-29 | 2018-01-09 | 上虞新和成生物化工有限公司 | The method that immobilization esterase E.coli BioH catalyze and synthesize Retinol Palmitate |
CN105441521A (en) * | 2014-09-01 | 2016-03-30 | 浙江工业大学 | Synthetic method of vitamin A palmitate |
CN106916804A (en) * | 2017-04-05 | 2017-07-04 | 牡丹江医学院 | A kind of preparation method of vitamin A fatty acid ester synthesis immobilized lipase |
CN107099560B (en) * | 2017-04-24 | 2021-01-15 | 浙江工商大学 | Method for enzymatically synthesizing kojic acid lauric acid monoester in microwave-assisted ionic liquid and application of method |
CN107099560A (en) * | 2017-04-24 | 2017-08-29 | 浙江工商大学 | The method and its application of enzyme' s catalysis kojic acid lauric acid monoester in a kind of ionic liquid of microwave radiation technology |
CN109234262A (en) * | 2018-09-17 | 2019-01-18 | 北京化工大学 | A kind of method that carrier granulating technique prepares immobilised enzymes |
CN109234262B (en) * | 2018-09-17 | 2022-07-08 | 北京化工大学 | Method for preparing immobilized enzyme by carrier granulation technology |
CN109777793A (en) * | 2019-03-15 | 2019-05-21 | 常熟理工学院 | A kind of GDSL lipase, genetic engineering bacteria and application thereof |
CN109777793B (en) * | 2019-03-15 | 2020-12-08 | 常熟理工学院 | A kind of GDSL lipase, genetic engineering bacteria and application thereof |
WO2021056683A1 (en) * | 2019-09-27 | 2021-04-01 | 常熟理工学院 | Strain for producing lipase and application thereof |
CN114901816A (en) * | 2019-12-30 | 2022-08-12 | 帝斯曼知识产权资产管理有限公司 | Lipase-modified strains |
CN114214371A (en) * | 2021-12-20 | 2022-03-22 | 源创核新(北京)新材料科技有限公司 | A kind of method of lipase-catalyzed synthesis of glycol carbonate |
CN114854717A (en) * | 2022-05-07 | 2022-08-05 | 万华化学集团股份有限公司 | Lipase, and coding gene and application thereof |
CN114854717B (en) * | 2022-05-07 | 2023-08-11 | 万华化学集团股份有限公司 | Lipase and encoding gene and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101200740A (en) | A method for preparing vitamin A fatty acid ester catalyzed by lipase | |
Remonatto et al. | Applications of immobilized lipases in enzymatic reactors: A review | |
Mendes et al. | Properties and biotechnological applications of porcine pancreatic lipase | |
Eş et al. | Principles, techniques, and applications of biocatalyst immobilization for industrial application | |
Fernandez-Lafuente | Lipase from Thermomyces lanuginosus: uses and prospects as an industrial biocatalyst | |
Rodrigues et al. | Lipase from Rhizomucor miehei as an industrial biocatalyst in chemical process | |
Kimura et al. | Application of immobilized lipase to hydrolysis of triacylglyceride | |
Xu et al. | Biosynthesis of ethyl esters of short-chain fatty acids using whole-cell lipase from Rhizopus chinesis CCTCC M201021 in non-aqueous phase | |
US6596520B1 (en) | Immobilizing lipase by adsorption from a crude solution onto nonpolar polyolefin particles | |
JP2729044B2 (en) | Microbial esterases that hydrolyze stereoselectively and uses thereof | |
Nawani et al. | Immobilization and stability studies of a lipase from thermophilic Bacillus sp: The effect of process parameters on immobilization of enzyme | |
Rodrigues et al. | Two step ethanolysis: A simple and efficient way to improve the enzymatic biodiesel synthesis catalyzed by an immobilized–stabilized lipase from Thermomyces lanuginosus | |
Liu et al. | A review on lipase-catalyzed synthesis of geranyl esters as flavor additives for food, pharmaceutical and cosmetic applications | |
Gamayurova et al. | Lipases in esterification reactions: a review | |
CN102676592A (en) | Application of lipase SMG1 in preparation of fatty acid monoglyceride | |
Kuang et al. | Silica@ lipase hybrid biocatalysts with superior activity by mimetic biomineralization in oil/water two-phase system for hydrolysis of soybean oil | |
Kovalenko et al. | Lipase-active heterogeneous biocatalysts for enzymatic synthesis of short-chain aroma esters | |
Momsia et al. | A review on microbial lipase-versatile tool for industrial applications | |
Yuan et al. | Rice straw enhancing catalysis of Pseudomonas fluorescens lipase for synthesis of citronellyl acetate | |
Ondul et al. | Biocatalytic production of biodiesel from vegetable oils | |
JPH01137988A (en) | Production of ester exchanged fat by continuous ester exchange method using alkaline high molecular weight lipase | |
Eskandari et al. | Recent insight into the advances and prospects of microbial lipases and their potential applications in industry | |
Jiang et al. | Synthesis of phytosterol esters catalyzed by immobilized lipase in organic media | |
Hussain et al. | Lipases: sources, immobilization techniques, and applications | |
Wang et al. | Ectoine improves yield of biodiesel catalyzed by immobilized lipase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20080618 |